Researchers tested the accuracy of real-time polymerase chain reaction for detecting CDAD after infection rates at the hospital increased following PCR usage for detection.
Researchers screened patients for C. diff using real-time PCR, a toxin enzyme-linked immunosorbent assay and a toxigenic culture.
C. diff was detected in 18 percent of the participants using real-time PCR detection. Of the patients with detected C. diff, 72 percent had asymptomatic C. diff colonization.
Researchers suggest PCR detection may be contributing to the rising rates of CDAD by reporting false positives, as asymptomatic C. diff colonization is overrepresented in actual CDAD rates. They also suggest further studies are needed to develop a standard in CDAD diagnostic testing and to guide PCR detection interpretation.
More Articles on C. diff:
Most Common Healthcare-Associated Infections: 25 Bacteria, Viruses Causing HAIs
Sepsis Patients With C. diff Infections Linked to Increased Mortality, LOS, Cost
Concord Hospital Uses UV Light Robot to Target C. Diff
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
